New

Global ETF Survey Is Live! 600+ ETF Professionals Weigh In. See Results →

Advertisement
Advertisement

WisdomTree BioRevolution Fund

This ETF provides exposure to Equally Weighted Developed markets Equities

WDNA performance and flow charts

Last update 11/2/2026 at 4:49 PM
Live
Closed
Last price
$23.76
-$0.34 (-1.43%) Today

Performance

-8.0-6.0-4.0-2.00.02.0%Sep 30Oct 7Oct 14Oct 21Oct 28

Flows

050,000100,000150,000200,000
1 day price range
$23.76
$23.76
52 week price range
$16.05
$24.65
1W perf
+4.62%
YTD perf
+42.28%
YTD flows
+$1M
AuM
$5M
E/R
0.45%
TTM yield
3.2%
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of October 30, 2026
1M3MYTD1Y3Y5Y
Perf.+0.27%+20.95%+42.28%+48.19%+89.18%-1.48%
Flows+$239K+$2M+$1M+$1M+$1M+$3M
Data as of October 30, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

The WisdomTree BioRevolution Fund is built to track the WisdomTree BioRevolution ESG Screened Net Return Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.

Management strategyPassive
StrategyLong Only
ProviderWisdomTree
N° of holdings79
Replication methodDirect (Physical)
Asset classEquity
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateJune 3, 2021
ESGYes
TrackinsightTrackinsight

More data and info about WDNA on Trackinsight

Exposure

Data as of September 30, 2026

Diversification

50.08%

Total weight of top 15 holdings out of 79

Top 15 Holdings

Moderna, Inc.
10.44%
Twist Bioscience Corp.
9.31%
10X Genomics, Inc.
3.68%
Eli Lilly & Co.
3.47%
Natera, Inc.
3.09%
Tempus AI, Inc.
2.82%
Johnson & Johnson
2.69%
Iovance Biotherapeutics, Inc.
2.32%
Immunome, Inc.
2.02%
United Therapeutics Corp.
1.86%
Darling Ingredients, Inc.
1.85%
Thermo Fisher Scientific, Inc.
1.75%
Revolution Medicines, Inc.
1.6%
Corteva, Inc.
1.58%
CRISPR Therapeutics AG
1.58%

Sectors

Healthcare
90.77%
Other
9.23%

Countries

USA
86.29%
Other
13.71%
Advertisement

Trading data

Last sale
11/2/2026 at 4:49 PM
$23.76
Previous close
$24.11
Consolidated volume
10/30/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+38.53%+28.31%+26.80%+26.11%
Max drawdown
-8.13%-11.90%-36.45%-56.39%
Max drawdown duration
38d147d595d1822d
Time to recover
23d84d190dN/A
Data will be available soon

Replication quality

Data as of November 2, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free
Tracking error
Join for free
Tracking difference
Join for free
1 year cumulative return difference
Best
Join for free
Worst
Join for free
daily return difference
Average
Join for free
Worst
Join for free
Advertisement
Frequently asked questions about WDNA

What type of ETF is WDNA?

WDNA is a Passive ETF that provides exposure to Equity assets. It is managed by WisdomTree.

What index does WDNA track?

WDNA tracks the WisdomTree BioRevolution ESG Screened Net Return Index - USD, aiming to replicate its performance through optimized sampling.

What does WDNA invest in?

This ETF provides exposure to Equally Weighted Developed markets Equities. It is part of the segment: BioTech & Genomics.

What is the expense ratio of WDNA?

The total expense ratio (TER) of WDNA is 0.45%, representing the annual fee charged by the fund manager.

When was WDNA launched?

WDNA was launched on June 3, 2021, marking its entry into the ETF market.

Who is the issuer of WDNA?

WDNA is issued by WisdomTree.

What is the AUM of WDNA?

As of October 30, 2026, WDNA manages $5.05 M, reflecting the total assets held in the fund.

How has WDNA performed recently?

As of October 30, 2026, WDNA delivered a return of 0.27% over the past month (1M performance), 20.95% over the past three months (3M), and 42.28% year-to-date (YTD).

What are the recent fund flows for WDNA?

As of October 30, 2026, WDNA has seen net flows of +$239K in the past month (1M flow) and +$1M year-to-date (YTD).

Does WDNA pay dividends?

As of October 30, 2026, WDNA has a trailing 12-month distribution yield of 3.2%.

How many holdings are in WDNA

As of September 30, 2026, WDNA holds 79 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is WDNA?

As of September 30, 2026, WDNA holds 79 securities, with 50.08% of its assets concentrated in its top 15 holdings.

What are the top holdings of WDNA?

As of September 30, 2026, WDNA holds a portfolio of 79 underlyings, with its largest positions including Moderna, Inc., Twist Bioscience Corp. and 10X Genomics, Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does WDNA invest in?

As of September 30, 2026, WDNA has its largest geographic exposures in USA.

What sectors or themes does WDNA focus on?

As of September 30, 2026, WDNA is primarily exposed to Healthcare.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides

Recent educational content

ETF Investing Trends - First Look

First Look ETF

First Look ETF: Income, International, and Cash Flow ETFs

In this season 6 episode of First Look ETF, Stephanie Stanton ‪@etfguide‬ examines the latest ETF marketplace trends with NYSE and guests.

ETF Guide
By ETF Guide · October 20, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs October 5, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · October 6, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 28, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 29, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 22, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 23, 2026

Browse all educational columns

Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026